CIC was also identified as a determinant of sensitivity to blocking EGFR signaling in neural stem cells or NSCLC cell lines [65,71], suggesting that inactivation of CIC may counteract MAPK inhibition in human cancer. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.